Stock-based Compensation (Tables)
|
6 Months Ended |
Jul. 05, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Total Stock-based Compensation Expense |
The following table summarizes the total stock-based compensation expense, by operating expense category, recognized in the Condensed Consolidated Statements of Operations for the periods presented below (in thousands). | | | | | | | | | | | | | | | | | | | | | | | | | Fiscal Quarters Ended | | Fiscal Years-to-Date Ended | | July 5,
2026 | | June 29,
2025 | | July 5, 2026 | | June 29, 2025 | | Cost of revenue | $ | 490 | | | $ | 356 | | | $ | 935 | | | $ | 477 | | | Research and development | 4,620 | | | 6,941 | | | 9,690 | | | 13,296 | | | Selling, general and administrative | 7,924 | | | 6,825 | | | 14,174 | | | 12,363 | | | | | | | | | | | Total stock-based compensation expense | $ | 13,034 | | | $ | 14,122 | | | $ | 24,799 | | | $ | 26,136 | |
|
| Schedule of Stock Option Activity |
The following table summarizes stock option activities for the fiscal year-to-date ended July 5, 2026 (in thousands, except share, per share and contractual life amounts). | | | | | | | | | | | | | | | | | | | | | | | | | Number of
Options
Outstanding | | Weighted
Average
Exercise
Price | | Weighted
Average
Remaining
Contractual
Life (Years) | | Aggregate Intrinsic Value (1) (2) | | Balances as of December 29, 2025 | 1,206,554 | | $ | 9.69 | | | 5.2 | | $ | 219 | | | | | | | | | | | Exercised | (4,730) | | 0.05 | | | | | | | Forfeited | (69,623) | | 8.81 | | | | | | | Balances as of July 5, 2026 | 1,132,201 | | $ | 9.78 | | | 4.4 | | $ | 99 | | | Vested and expected to vest at July 5, 2026 | 1,132,201 | | | $ | 9.78 | | | 4.4 | | $ | 99 | | | Vested and exercisable at July 5, 2026 | 1,131,367 | | | $ | 9.77 | | | 4.4 | | $ | 99 | | | Unvested and exercisable at July 5, 2026 | 834 | | | $ | 17.99 | | | 0.3 | | $ | — | |
| | | | | | | (1) | The intrinsic value of options exercised is based upon the value of our stock at exercise. | | (2) | The aggregate intrinsic value of the stock options outstanding as of July 5, 2026 represents the value of our closing stock price at $5.36 on the last trading day of the quarter ended July 5, 2026 in excess of the exercise price multiplied by the number of options outstanding. |
|
| Schedule of RSUs and PRSUs Activity |
The following table summarizes RSUs and PRSUs activities for the fiscal year-to-date ended July 5, 2026 (in thousands, except share and per share amount). | | | | | | | | | | | | | | | | | | | | | | | | | RSUs | | PRSUs | | Number of
Shares
Outstanding | | Weighted Average
Grant Date Fair Value | | Number of
Shares
Outstanding | | Weighted Average
Grant Date Fair Value | | Issued and unvested shares balances as of December 29, 2025 | 10,336,628 | | | $ | 8.75 | | | 2,047,638 | | | $ | 7.51 | | | Granted | 6,078,478 | | | 5.45 | | | 2,230,318 | | | 5.14 | | | Vested | (2,856,396) | | | 8.37 | | | (16,748) | | | 8.25 | | | Forfeited | (1,489,300) | | | 9.43 | | | (945,580) | | | 7.35 | | | Issued and unvested shares outstanding as of July 5, 2026 | 12,069,410 | | | $ | 7.09 | | | 3,315,628 | | | $ | 5.99 | |
|